PlainBillCongress, translated.Legislation. Context. Public interest.Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4625)
Congressional Research Service
Version 00 · Introduced in Senate · Jun 17, 2021
Personal Care Products Safety Act
This bill requires cosmetics brands and manufacturers to register with the Food and Drug Administration (FDA), provides the FDA with various regulatory authorities, and addresses related issues.
Cosmetics brand owners and contract manufacturers must annually register their manufacturing facilities with the FDA. Certain entities and facilities, such as manufacturers with gross sales below certain thresholds, are exempted. Registrants with gross annual sales above certain thresholds must pay a registration fee.
Showing the opening paragraphs of the official summary.
Each registration must contain certain information, including an ingredient list for all cosmetic products from a registered facility, with different requirements for registrants that qualify as small businesses.
The FDA may suspend a registration for various reasons, including if the registrant's product has a reasonable probability of causing serious adverse health consequences and the problem cannot be isolated to a single product.
The FDA must annually conduct a safety review of at least five cosmetics ingredients or nonfunctional constituents and, if appropriate, issue a final finding on the safety of that ingredient or constituent. The FDA must also implement regulations for good cosmetics manufacturing practices.
The bill also requires cosmetics brand owners and manufacturers to report to the FDA any serious adverse event associated with their products.
The FDA shall have various authorities to regulate cosmetics, including to (1) order a mandatory recall of a product, (2) inspect the records of manufacturers and processors, and (3) require warning labels for certain products.
The FDA must issue a proposed rule to ban using intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics.
People & committees
Sen. Feinstein, Dianne [D-CA] · D–CA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4625)
Introduced in Senate
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Apr 21, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze S.2100 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine S.2100 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine S.2100 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine S.2100 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.